Research and Markets has announced the addition of the "Global Liquid Biopsy Market 2017-2021" report to their offering.
The global liquid biopsy market to grow at a CAGR of 20.31% during the period 2017-2021.
The report, Global Liquid Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
New players approach venture capitalists to enter into niche markets like a liquid biopsy. These venture capitalists started realizing the significant potential of start-ups that develop innovative technologies and products in the area of cancer. This has increased the financial flow support from venture capitalists, which is accelerating the development of liquid biopsy products and is leading to the market entry of start-ups. Post registration and market approvals, venture capitalists take a share from the total revenue generated by the start-ups.
According to the report, the Americas is the major contributor in the market. The rising older population in the Americas is one of the major factors for increased adoption of liquid biopsy tests. Aging causes the immune system of the body to deteriorate. This makes most people aged 60 and above susceptible to chronic diseases such as cancer and cardiovascular diseases. The incidence of breast cancer and colorectal cancer is increasing due to the rise in the number of older people.
Key vendors
- Biocept
- Exosome Diagnostics
- QIAGEN
- Roche Molecular Diagnostics
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Market segmentation by end-user
PART 08: Geographical segmentation
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/m5wtgp/global_liquid.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170411005865/en/
Contacts:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics